These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9914949)

  • 21. Cytokines and autoimmunity.
    O'Shea JJ; Ma A; Lipsky P
    Nat Rev Immunol; 2002 Jan; 2(1):37-45. PubMed ID: 11905836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APC-derived cytokines and T cell polarization in autoimmune inflammation.
    Gutcher I; Becher B
    J Clin Invest; 2007 May; 117(5):1119-27. PubMed ID: 17476341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic changes in inflammatory and autoimmune diseases.
    Nielsen HM; Tost J
    Subcell Biochem; 2013; 61():455-78. PubMed ID: 23150263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type I interferons in systemic autoimmunity.
    Sozzani S; Bosisio D; Scarsi M; Tincani A
    Autoimmunity; 2010 Apr; 43(3):196-203. PubMed ID: 20298124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effector lymphocytes in autoimmunity.
    Santamaria P
    Curr Opin Immunol; 2001 Dec; 13(6):663-9. PubMed ID: 11677087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
    Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
    Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticytokine therapy--new approach to the treatment of autoimmune and cytokine-disturbance diseases.
    Skurkovich SV; Skurkovich B; Kelly JA
    Med Hypotheses; 2002 Dec; 59(6):770-80. PubMed ID: 12445524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kitasato Symposium 2010: new prospects for cytokines.
    Burmester GR; Lipsky PE; Dörner T;
    Arthritis Res Ther; 2010; 12(6):301. PubMed ID: 21235827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translating molecular insights in autoimmunity into effective therapy.
    Feldmann M
    Annu Rev Immunol; 2009; 27():1-27. PubMed ID: 19007330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.
    Plevy SE; Landers CJ; Prehn J; Carramanzana NM; Deem RL; Shealy D; Targan SR
    J Immunol; 1997 Dec; 159(12):6276-82. PubMed ID: 9550432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine inhibitors in autoimmune disease.
    Weckmann AL; Alcocer-Varela J
    Semin Arthritis Rheum; 1996 Oct; 26(2):539-57. PubMed ID: 8916298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity.
    Elenkov IJ; Chrousos GP
    Ann N Y Acad Sci; 2002 Jun; 966():290-303. PubMed ID: 12114286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-regulation of TNF and IFN-alpha in autoimmune diseases.
    Palucka AK; Blanck JP; Bennett L; Pascual V; Banchereau J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3372-7. PubMed ID: 15728381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis.
    Firestein GS
    J Clin Invest; 2004 Aug; 114(4):471-4. PubMed ID: 15314683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine-regulated proteases in autoimmune diseases.
    Opdenakker G; Van Damme J
    Immunol Today; 1994 Mar; 15(3):103-7. PubMed ID: 8172641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modern anti-cytokine therapy of autoimmune diseases.
    Astrakhantseva IV; Efimov GA; Drutskaya MS; Kruglov AA; Nedospasov SA
    Biochemistry (Mosc); 2014 Dec; 79(12):1308-21. PubMed ID: 25716724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmunity: break-through in the diagnosis and treatment of immune-mediated inflammatory diseases.
    Kroese FG; Baeten D; Huizinga TW
    Immunol Lett; 2014 Dec; 162(2 Pt B):150-62. PubMed ID: 25455603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8+ T cells in autoimmunity.
    Walter U; Santamaria P
    Curr Opin Immunol; 2005 Dec; 17(6):624-31. PubMed ID: 16226438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.